Martin Verkuyl has over 15 years of experience in the areas of biotech, pharma, and medical nutrition. After a postdoctoral fellow position at the FMI in Basel, he began his industry career at Novartis in the UK, where he led a pharmacology laboratory. As a global project leader, he guided drug discovery projects from hit finding to lead optimalisation, and through pharmacokinetic and pharmacodynamic characterisation to pre-IND toxicity studies.

In 2014, he returned to the Netherlands to lead the Neuroscience Discovery team at Nutricia Research in Utrecht. With his team, he developed new nutritional concepts for Neurology, ensured IP protection of Nutricia’s Neurology product portfolio, and supported and initiated biomarker research and clinical trials.

On 2021, he joined Scenic Biotech (Amsterdam), as a Senior Program Director leading drug discovery programs for rare diseases. Here he oversaw the drug discovery activities of in-house generated targets, guided translational research, and helped to define the Target Product Profile and the clinical trial plan.

As a Biotech Booster Business Developer at Business Generator Groningen, he will support scientist from the RUG and the UMCG with valorisation of their biomedical research. His focus will be on the Advanced Therapy Medicinal Products (ATMPs) — therapies based on genes, cells or tissues – as well as biopharmaceutical, such as therapeutic antibodies or peptides.

Please feel free to contact Martin directly.